Protein-energy wasting and nutritional supplementation in patients with end-stage renal disease on hemodialysis

Sabatino, Alice; Regolisti, Giuseppe; Karupaiah, Tilakavati; Sahathevan, Sharmela; Singh, B. P.; Khor, Ban-Hock; Salhab, Nada; Karavetian, Mirey; Cupisti, Adamasco; Fiaccadori, Enrico

doi:10.1016/j.clnu.2016.06.007

Cited by 138 publications

(132 citation statements)

References 41 publications

Supporting

Mentioning

125

Contrasting

Unclassified

Order By: Relevance

“…2). Cuando añadimos suplementos orales nutricionales (SON) podemos incrementar hasta en 10 kcal/día y 0,3-0,4 g de proteínas por kg de peso (39).…”

Section: Peso Ajustado = [(Peso Real -Peso Ideal)] X 025 + Peso Idealunclassified

“…La transición desde la NE a la oral debe hacerse lentamente hasta asegurarnos de que es capaz de ingerir al menos un 70% de las necesidades calóricas diarias (39). Una forma útil de realizarla es mediante la NE cíclica nocturna a la vez que se estimula la ingesta oral durante el día.…”

Section: Peso Ajustado = [(Peso Real -Peso Ideal)] X 025 + Peso Idealunclassified

“…la supervivencia, con un efecto positivo sobre la albúmina sérica, inflamación, mortalidad y tasa de hospitalización (46). La NOID puede antagonizar el catabolismo inducido por la HD, manteniendo este efecto incluso después de finalizar la sesión de HD (39,46).…”

Section: Nutrición Oral Intradiálisis (Noid)unclassified

“…Aunque debemos tener en cuenta que el aporte por esta vía es limitado a los días y horas de HD, se ha estimado que, con la NPID, no se puede aportar más de 25% de los requerimientos diarios. Estaría recomendado en pacientes con una ingesta oral superior a 20 kcal/día/kg y a 0,8-0,9 g/kg/día de proteínas (39). Se debe indicar si no es posible la suplementación oral y retirar cuando se garantice una correcta ingesta oral y niveles de albúmina mantenidos > 3,8 mg/ dl.…”

Section: Np Intradiálisis (Npid)unclassified

See 3 more Smart Citations

Abordaje nutricional del paciente con diabetes mellitus e insuficiencia renal crónica: a propósito de un caso

Beatriz¹

2017

Nutr Hosp

View full text Add to dashboard Cite

The prevention and treatment of chronic kidney disease (CKD) in diabetes through diet and lifestyle have been a topic of much interest over the years. Consideration of the type and amount of carbohydrate, protein and fat is required for optimal blood glucose control, for clinical outcomes related to renal function and for consideration of risk reduction for cardiovascular disease. Depending on the CKD stage different dietary changes should be considered protein-calorie malnutrition is common in chronic kidney disease patients and is a powerful predictor of morbidity and mortality. We review the nutritional management of a diabetic patient throughout the progression of their CKD.Abordaje nutricional del paciente con diabetes mellitus e insufi ciencia renal crónica, a propósito de un caso ResumenLa prevención y el tratamiento de la enfermedad renal crónica (ERC) en pacientes con diabetes ha sido un tema de gran interés a lo largo de los años. Para conseguir un adecuado control glucémico, una función renal estable y una reducción del riesgo cardiovascular, es fundamental un correcto aporte de hidratos de carbono, lípidos y proteínas. Las medidas dietéticas realizadas se irán modifi cando a lo largo de la evolución de la ERC. La malnutrición energético-proteica es muy frecuente en pacientes con ERC y diabetes y es un importante predictor de morbimortalidad. Revisamos el manejo nutricional de un paciente diabético a lo largo de la progresión de su ERC.

show abstract

“…2). Cuando añadimos suplementos orales nutricionales (SON) podemos incrementar hasta en 10 kcal/día y 0,3-0,4 g de proteínas por kg de peso (39).…”

Section: Peso Ajustado = [(Peso Real -Peso Ideal)] X 025 + Peso Idealunclassified

Section: Nutrición Oral Intradiálisis (Noid)unclassified

Section: Np Intradiálisis (Npid)unclassified

See 2 more Smart Citations

Abordaje nutricional del paciente con diabetes mellitus e insuficiencia renal crónica: a propósito de un caso

Beatriz¹

2017

Nutr Hosp

View full text Add to dashboard Cite

show abstract

“…Hemodialysis patients often have renal anemia, proteinenergy wasting (PEW), skeletal muscle loss, muscle weakness, skeletal muscle dysfunction, exercise intolerance, fatigue, decreased activity of daily living, and ultimately, declined quality of life (QOL) [1]. In addition to these consequences, hemodialysis patients tend to decrease their dietary intake, which causes sarcopenia [2].…”

Section: Introductionmentioning

confidence: 99%

Rehabilitation nutrition support for a hemodialysis patient with protein-energy wasting and sarcopenic dysphagia: a case report

Uno¹,

Wakabayashi

Maeda

et al. 2018

Ren Replace Ther

View full text Add to dashboard Cite

Background: Patients with end-stage renal failure may exhibit sarcopenia and protein-energy wasting (PEW). We report a case of improvement in physical function, muscle mass, and muscle strength by management of rehabilitation nutrition in a maintenance hemodialysis patient with PEW and sarcopenia. Case presentation: A 60-year-old man with an 8-year history of dialysis was admitted for pneumococcal meningitis. When he was transferred for rehabilitation 36 days following the onset, he was transferred to our hospital for rehabilitation and hemodialysis. On admission, energy intake was 1200 kcal/day, via a nasogastric tube, due to sarcopenic dysphagia. He was diagnosed with PEW, based on results from a biochemical examination, physical examination, and his low dietary intake. His height, dry weight, body mass index, Mini Nutritional Assessment-Short Form, albumin, C-reactive protein, and Geriatric Nutritional Risk Index were 166 cm, 46.5 kg, 16. 9 kg/m

show abstract

Diagnosis, prevalence, and outcomes of sarcopenia in kidney transplantation recipients: A systematic review and meta‐analysis

Zhang

Shi

Zou

et al. 2022

J cachexia sarcopenia muscle

View full text Add to dashboard Cite

The prevalence of sarcopenia and its clinical predictors and clinical impact vary among kidney transplant recipients (KTRs), in part because of different diagnostic criteria. This study aimed to assess the reported diagnosis criteria of sarcopenia and compare them in terms of prevalence, clinical predictors, and impact of sarcopenia. The Medline, Embase, and Cochrane Library were searched for the full-length reports published until 28 January 2022. The subgroup analysis, meta-regression, and sensitivity analysis were performed and heterogeneity was assessed using the I 2 . A total of 681 studies were retrieved, among which only 23 studies (including 2535 subjects, 59.7% men, mean age 49.8 years) were eventually included in the final analysis. The pooled prevalence in these included studies was 26% [95% confidence interval (95% CI): 20-34%, I 2 = 93.45%], including 22% (95% CI: 14-32%, I 2 = 88.76%) in men and 27% (95% CI: 14-41%, I 2 = 90.56%) in women (P = 0.554 between subgroups). The prevalence of sarcopenia diagnosed using low muscle mass was 34% (95% CI: 21-48%, I 2 = 95.28%), and the prevalence of using low muscle mass in combination with low muscle strength and/or low physical performance was 21% (95% CI: 15-28%, I 2 = 90.37%) (P = 0.08 between subgroups). In meta-regression analyses, the mean age (regression coefficient: 1.001, 95% CI: 0.991-1.011) and percentage male (regression coefficient: 0.846, 95% CI: 0.367-1.950) could not predict the effect size. Lower body mass index (odds ratio (OR): 0.57, 95% CI: 0.39-0.84, I 2 = 61.5%), female sex (OR: 0.31, 95% CI: 0.16-0.61, I 2 = 0.0%), and higher age (OR: 1.08, 95% CI: 1.05-1.10, I 2 = 10.1%) were significantly associated with a higher risk for sarcopenia in KTRs, but phase angle (OR: 0.81, 95% CI: 0.16-4.26, I 2 = 84.5%) was not associated with sarcopenia in KTRs. Sarcopenia was not associated with rejections (risk ratio (RR): 0.67, 95% CI: 0.23-1.92, I 2 = 12.1%), infections (RR: 1.03, 95% CI: 0.34-3.12, I 2 = 87.4%), delayed graft functions (RR: 0.81, 95% CI: 0.46-1.43, I 2 = 0.0%), and death (RR: 0.95, 95% CI: 0.32-2.82, I 2 = 0.0%) in KRTs. Sarcopenia was found to be very common in KRTs. However, we have not found that sarcopenia had a negative impact on clinical health after kidney transplantation. Large study cohorts and multicentre longitudinal studies in the future are urgently needed to explore the prevalence and prognosis of sarcopenia in kidney transplant patients.

show abstract

Protein-energy wasting and nutritional supplementation in patients with end-stage renal disease on hemodialysis

Cited by 138 publications

References 41 publications

Abordaje nutricional del paciente con diabetes mellitus e insuficiencia renal crónica: a propósito de un caso

Abordaje nutricional del paciente con diabetes mellitus e insuficiencia renal crónica: a propósito de un caso

Rehabilitation nutrition support for a hemodialysis patient with protein-energy wasting and sarcopenic dysphagia: a case report

Diagnosis, prevalence, and outcomes of sarcopenia in kidney transplantation recipients: A systematic review and meta‐analysis

Contact Info

Product

Resources

About